{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:20:28Z","timestamp":1780449628906,"version":"3.54.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T00:00:00Z","timestamp":1570060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41390-019-0591-5","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T07:07:31Z","timestamp":1571814451000},"page":"345-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["The promise of a prophylactic Epstein\u2013Barr virus vaccine"],"prefix":"10.1038","volume":"87","author":[{"suffix":"Jr.","given":"Henry H.","family":"Balfour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Schmeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Grimm-Geris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,3]]},"reference":[{"key":"591_CR1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A., Achong, B. G. & Barr, Y. M. Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 1, 702\u2013703 (1964).","journal-title":"Lancet"},{"key":"591_CR2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.mi.27.100173.002213","volume":"27","author":"MA Epstein","year":"1973","unstructured":"Epstein, M. A. & Achong, B. G. The EB virus. Annu Rev. Microbiol. 27, 413\u2013436 (1973).","journal-title":"Annu Rev. Microbiol."},{"key":"591_CR3","unstructured":"Robertson, E. S. (ed). Epstein\u2013Barr Virus 1\u201314 (Caister Academic Press, Norfolk)."},{"key":"591_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D Burkitt","year":"1958","unstructured":"Burkitt, D. A sarcoma involving the jaws in African children. Br. J. Surg. 46, 218\u2013223 (1958).","journal-title":"Br. J. Surg."},{"key":"591_CR5","first-page":"1","volume":"4","author":"NK El-Mallawany","year":"2017","unstructured":"El-Mallawany, N. K. et al. Beyond endemic Burkitt lymphoma: navigating challenges of differentiating childhood lymphoma diagnoses amid limitations in pathology resources in Lilongwe, Malawi. Glob. Pediatr. Health 4, 1\u201312 (2017).","journal-title":"Glob. Pediatr. Health"},{"key":"591_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.22179","volume":"120","author":"JJ Rainey","year":"2007","unstructured":"Rainey, J. J. et al. Spatial clustering of endemic Burkitt\u2019s lymphoma in high-risk regions of Kenya. Int. J. Cancer 120, 121\u2013127 (2007).","journal-title":"Int. J. Cancer"},{"key":"591_CR7","volume-title":"Semeiology and Diagnosis of Diseases of Children: Together with a Therapeutic Index","author":"N Filatov","year":"1904","unstructured":"Filatov, N. & Earle, F. B. Semeiology and Diagnosis of Diseases of Children: Together with a Therapeutic Index (Cleveland Press, Chicago, 1904)."},{"key":"591_CR8","first-page":"257","volume":"29","author":"E Pfeiffer","year":"1889","unstructured":"Pfeiffer, E. Dr\u00fcsenfieber. Jahrb. f.\u00fcr. Kinderheilkd. und Phys. Erziehung (Wien.) 29, 257\u2013264 (1889).","journal-title":"Jahrb. f.\u00fcr. Kinderheilkd. und Phys. Erziehung (Wien.)"},{"key":"591_CR9","first-page":"410","volume":"31","author":"TP Sprunt","year":"1920","unstructured":"Sprunt, T. P. & Evans, F. A. Mononuclear leucocytosis in reaction to acute infections (\u201cinfectious mononucleosis\u201d). Johns Hopkins Hosp. Bull. 31, 410\u2013417 (1920).","journal-title":"Johns Hopkins Hosp. Bull."},{"key":"591_CR10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/archinte.1923.00110190085006","volume":"32","author":"H Downey","year":"1923","unstructured":"Downey, H. & McKinlay, C. A. Acute lymphadenosis compared with acute lymphatic leukemia. Arch. Intern. Med. 32, 82\u2013112 (1923).","journal-title":"Arch. Intern. Med."},{"key":"591_CR11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm0896-906","volume":"2","author":"MF Callan","year":"1996","unstructured":"Callan, M. F. et al. Large clonal expansions of CD8+ T cells in acute infectious mononucleosis. Nat. Med. 2, 906\u2013911 (1996).","journal-title":"Nat. Med."},{"key":"591_CR12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00000441-193201000-00010","volume":"183","author":"JR Paul","year":"1932","unstructured":"Paul, J. R. & Bunnell, W. W. The presence of heterophile antibodies in infectious mononucleosis. Am. J. Med. Sci. 183, 90\u2013104 (1932).","journal-title":"Am. J. Med. Sci."},{"key":"591_CR13","unstructured":"zur Hausen, H. in Epstein\u2013Barr virus (ed. Robertson, E. S.) 15\u201322 (Caister Academic Press, Norfolk, 2005)."},{"key":"591_CR14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/000992287201100711","volume":"11","author":"HH Balfour Jr.","year":"1972","unstructured":"Balfour, H. H. Jr., Forte, F. A., Simpson, R. B. & Zolov, D. M. Penicillin-related exanthems in infectious mononucleosis identical to those associated with ampicillin. Clin. Pediatr. (Philos.) 11, 417\u2013421 (1972).","journal-title":"Clin. Pediatr. (Philos.)"},{"key":"591_CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1073\/pnas.59.1.94","volume":"59","author":"G Henle","year":"1968","unstructured":"Henle, G., Henle, W. & Diehl, V. Relation of Burkitt\u2019s tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 59, 94\u2013101 (1968).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"591_CR16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jis646","volume":"207","author":"HH Balfour","year":"2013","unstructured":"Balfour, H. H. et al. Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein\u2013Barr virus infection in university students. J. Infect. Dis. 207, 80\u201388 (2013).","journal-title":"J. Infect. Dis."},{"key":"591_CR17","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/cti.2016.48","volume":"5","author":"JM Grimm","year":"2016","unstructured":"Grimm, J. M. et al. Prospective studies of infectious mononucleosis in university students. Clin. Transl. Immunol. 5, e94 (2016).","journal-title":"Clin. Transl. Immunol."},{"key":"591_CR18","first-page":"e140, 1","volume":"147","author":"JM Grimm-Geris","year":"2019","unstructured":"Grimm-Geris, J. M. et al. Screening for Epstein\u2013Barr virus (EBV) infection status in university freshmen: acceptability of a gingival swab method. Epidemiol. Infect. 147, e140, 1\u20136 (2019).","journal-title":"Epidemiol. Infect."},{"key":"591_CR19","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1056\/NEJM197312202892501","volume":"289","author":"RS Chang","year":"1973","unstructured":"Chang, R. S., Lewis, J. P. & Abildgaard, C. F. Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N. Engl. J. Med. 289, 1325\u20131329 (1973).","journal-title":"N. Engl. J. Med."},{"key":"591_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.7326\/0003-4819-88-1-34","volume":"88","author":"RS Chang","year":"1978","unstructured":"Chang, R. S., Lewis, J. P., Reynolds, R. D., Sullivan, M. J. & Neuman, J. Oropharyngeal excretion of Epstein\u2013Barr virus by patients with lymphoproliferative disorders and by recipients of renal homografts. Ann. Intern. Med. 88, 34\u201340 (1978).","journal-title":"Ann. Intern. Med."},{"key":"591_CR21","first-page":"4253","volume":"41","author":"DW Hanto","year":"1981","unstructured":"Hanto, D. W. et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein\u2013Barr virus. Cancer Res. 41, 4253\u20134261 (1981).","journal-title":"Cancer Res."},{"key":"591_CR22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198204153061506","volume":"306","author":"DW Hanto","year":"1982","unstructured":"Hanto, D. W. et al. Epstein\u2013Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N. Engl. J. Med. 306, 913\u2013918 (1982).","journal-title":"N. Engl. J. Med."},{"key":"591_CR23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","volume":"70","author":"SL Glaser","year":"1997","unstructured":"Glaser, S. L. et al. Epstein\u2013Barr virus-associated Hodgkin\u2019s disease: epidemiologic characteristics in international data. Int. J. Cancer 70, 375\u2013382 (1997).","journal-title":"Int. J. Cancer"},{"key":"591_CR24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/jama.1953.02940120028005c","volume":"151","author":"FC Massey","year":"1953","unstructured":"Massey, F. C., Lane, L. L. & Inbriglia, J. E. Acute infectious mononucleosis and Hodgkin\u2019s disease occurring simultaneously in the same patient. J. Am. Med Assoc. 151, 994\u2013995 (1953).","journal-title":"J. Am. Med Assoc."},{"key":"591_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1159\/000205498","volume":"29","author":"Y Kenis","year":"1958","unstructured":"Kenis, Y., Dustin, P. Jr & Peltzer, T. Un cas de maladie Hodgkin avec syndrome h\u00e9matologique et s\u00e9rologique de mononucl\u00e9ose infectieuse. Acta Haematol. 29, 329\u2013336 (1958).","journal-title":"Acta Haematol."},{"key":"591_CR26","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1056\/NEJMoa023141","volume":"349","author":"H Hjalgrim","year":"2003","unstructured":"Hjalgrim, H. et al. Characteristics of Hodgkin\u2019s lymphoma after infectious mononucleosis. N. Engl. J. Med. 349, 1324\u20131332 (2003).","journal-title":"N. Engl. J. Med."},{"key":"591_CR27","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1158\/0008-5472.CAN-06-3566","volume":"67","author":"H Hjalgrim","year":"2007","unstructured":"Hjalgrim, H. et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma. Cancer Res. 67, 2382\u20132388 (2007).","journal-title":"Cancer Res."},{"issue":"1","key":"591_CR28","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/asheducation-2007.1.204","volume":"2007","author":"Richard F. Ambinder","year":"2007","unstructured":"Ambinder, R. F. Epstein\u2013Barr virus and Hodgkin lymphoma. Hematol. Am. Soc. Hematol. Educ. Program 2007, 204\u2013209 (2007).","journal-title":"Hematology"},{"key":"591_CR29","unstructured":"Xu, B. Nonkeratinizing squamous cell carcinoma\u2014undifferentiated. PathologyOutlines.com website. http:\/\/www.pathologyoutlines.com\/topic\/nasalnonkeratinizingundiff.html. Accessed 3 Mar 2019."},{"key":"591_CR30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.semdp.2015.02.021","volume":"32","author":"F Petersson","year":"2015","unstructured":"Petersson, F. Nasopharyngeal carcinoma: a review. Semin. Diagn. Pathol. 32, 54\u201373 (2015).","journal-title":"Semin. Diagn. Pathol."},{"key":"591_CR31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5732\/cjc.010.10377","volume":"30","author":"S-M Cao","year":"2011","unstructured":"Cao, S.-M., Simons, M. J. & Qian, C. N. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin. J. Cancer 30, 114\u2013119 (2011).","journal-title":"Chin. J. Cancer"},{"key":"591_CR32","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1073\/pnas.56.6.1699","volume":"56","author":"LJ Old","year":"1966","unstructured":"Old, L. J. et al. Precipitating antibody in human serum to an antigen present in cultured Burkitt\u2019s lymphoma cells. Proc. Natl. Acad. Sci. USA 56, 1699\u20131704 (1966).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"591_CR33","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","volume":"228","author":"H zur Hausen","year":"1970","unstructured":"zur Hausen, H. et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228, 1056\u20131058 (1970).","journal-title":"Nature"},{"key":"591_CR34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1097-0142(197505)35:5<1313::AID-CNCR2820350510>3.0.CO;2-B","volume":"35","author":"WM Wara","year":"1975","unstructured":"Wara, W. M., Wara, D. W., Phillips, T. L. & Ammann, A. J. Elevated IGA in carcinoma of the nasopharynx. Cancer 35, 1313\u20131315 (1975).","journal-title":"Cancer"},{"key":"591_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910170102","volume":"17","author":"G Henle","year":"1976","unstructured":"Henle, G. & Henle, W. Epstein\u2013Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int. J. Cancer 17, 1\u20137 (1976).","journal-title":"Int. J. Cancer"},{"key":"591_CR36","first-page":"1188","volume":"59","author":"YM Lo","year":"1999","unstructured":"Lo, Y. M. et al. Quantitative analysis of cell-free Epstein\u2013Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 59, 1188\u20131191 (1999).","journal-title":"Cancer Res."},{"key":"591_CR37","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/0008-5472.CAN-12-2448","volume":"73","author":"EP Hui","year":"2013","unstructured":"Hui, E. P. et al. Phase I trial of recombinant modified vaccinia ankara encoding Epstein\u2013Barr viral tumor antigens in nasopharyngeal carcinoma patients. Cancer Res. 73, 1676\u20131688 (2013).","journal-title":"Cancer Res."},{"key":"591_CR38","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/1078-0432.CCR-14-1122-T","volume":"20","author":"GS Taylor","year":"2014","unstructured":"Taylor, G. S. et al. A recombinant modified vaccinia ankara vaccine encoding Epstein\u2013Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer. Clin. Cancer Res. 20, 5009\u20135022 (2014).","journal-title":"Clin. Cancer Res."},{"key":"591_CR39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00001648-200003000-00023","volume":"11","author":"A Ascherio","year":"2000","unstructured":"Ascherio, A. & Munch, M. Epstein\u2013Barr virus and multiple sclerosis. Epidemiology 11, 220\u2013224 (2000).","journal-title":"Epidemiology"},{"key":"591_CR40","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","volume":"6","author":"B Banwell","year":"2007","unstructured":"Banwell, B. et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol. 6, 773\u2013781 (2007).","journal-title":"Lancet Neurol."},{"key":"591_CR41","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","volume":"17","author":"KL Munger","year":"2011","unstructured":"Munger, K. L., Levin, L. I., O\u2019Reilly, E. J., Falk, K. I. & Ascherio, A. Anti-Epstein\u2013Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult. Scler. 17, 1185\u20131193 (2011).","journal-title":"Mult. Scler."},{"key":"591_CR42","doi-asserted-by":"crossref","first-page":"e12496","DOI":"10.1371\/journal.pone.0012496","volume":"5","author":"AE Handel","year":"2010","unstructured":"Handel, A. E. et al. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS ONE 5, e12496 (2010).","journal-title":"PLoS ONE"},{"key":"591_CR43","doi-asserted-by":"crossref","first-page":"e1003220","DOI":"10.1371\/journal.ppat.1003220","volume":"9","author":"DF Angelini","year":"2013","unstructured":"Angelini, D. F. et al. Increased CD8+ T cell response to Epstein\u2013Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog. 9, e1003220 (2013).","journal-title":"PLoS Pathog."},{"key":"591_CR44","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1093\/brain\/aws315","volume":"136","author":"B Serafini","year":"2013","unstructured":"Serafini, B., Muzio, L., Rosicarelli, B. & Aloisi, F. Radioactive in situ hybridization for Epstein\u2013Barr virus-encoded small RNA supports presence of Epstein\u2013Barr virus in the multiple sclerosis brain. Brain 136, e233 (2013).","journal-title":"Brain"},{"key":"591_CR45","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1212\/NXI.0000000000000466","volume":"5","author":"MA Moreno","year":"2018","unstructured":"Moreno, M. A. et al. Molecular signature of Epstein\u2013Barr virus infection in MS brain lesions. Neurol. Neuroimmunol. Neuroinflamm. 5, e466 (2018).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"591_CR46","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/1352458514521888","volume":"20","author":"MP Pender","year":"2014","unstructured":"Pender, M. P. et al. Epstein\u2013Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis. Mult. Scler. 20, 1541\u20131544 (2014).","journal-title":"Mult. Scler."},{"key":"591_CR47","doi-asserted-by":"crossref","unstructured":"Pender, M. P. et al. Epstein\u2013Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI Insight 3, e124714 (2018).","DOI":"10.1172\/jci.insight.124714"},{"key":"591_CR48","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/aje\/kwi280","volume":"162","author":"NM Nielsen","year":"2005","unstructured":"Nielsen, N. M. et al. Familial risk of multiple sclerosis: a nationwide cohort study. Am. J. Epidemiol. 162, 774\u2013778 (2005).","journal-title":"Am. J. Epidemiol."},{"key":"591_CR49","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016).","journal-title":"Blood"},{"key":"591_CR50","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen, J. I. et al. Characterization and treatment of chronic active Epstein\u2013Barr virus disease: a 28-year experience in the United States. Blood 117, 5835\u20135849 (2011).","journal-title":"Blood"},{"key":"591_CR51","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/25785826.2018.1556030","volume":"41","author":"A Arai","year":"2018","unstructured":"Arai, A. Chronic active Epstein\u2013Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements. Immunol. Med. 41, 162\u2013169 (2018).","journal-title":"Immunol. Med."},{"key":"591_CR52","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","volume":"196","author":"EM Sokal","year":"2007","unstructured":"Sokal, E. M. et al. Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein\u2013Barr virus vaccine in healthy young adults. J. Infect. Dis. 196, 1749\u20131753 (2007).","journal-title":"J. Infect. Dis."},{"key":"591_CR53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jcv.2018.03.001","volume":"102","author":"SK Dunmire","year":"2018","unstructured":"Dunmire, S. K., Verghese, P. S. & Balfour, H. H. Jr. Primary Epstein\u2013Barr virus infection. J. Clin. Virol. 102, 84\u201392 (2018).","journal-title":"J. Clin. Virol."},{"key":"591_CR54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/jnci\/56.4.697","volume":"56","author":"MA Epstein","year":"1976","unstructured":"Epstein, M. A. Epstein\u2013Barr virus\u2014is it time to develop a vaccine program? J. Natl. Cancer Inst. 56, 697\u2013700 (1976).","journal-title":"J. Natl. Cancer Inst."},{"key":"591_CR55","first-page":"989","volume":"45","author":"G Pearson","year":"1970","unstructured":"Pearson, G., Dewey, F., Klein, G., Henle, G. & Henle, W. Relation between neutralization of Epstein\u2013Barr virus and antibodies to cell-membrane antigens-induced by the virus. J. Natl. Cancer Inst. 45, 989\u2013995 (1970).","journal-title":"J. Natl. Cancer Inst."},{"key":"591_CR56","first-page":"171","volume":"84","author":"SY Gu","year":"1995","unstructured":"Gu, S. Y. et al. First EBV vaccine trial in humans using recombinant vaccinia virus expressing the major membrane antigen. Dev. Biol. Stand. 84, 171\u2013177 (1995).","journal-title":"Dev. Biol. Stand."},{"key":"591_CR57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3121\/cmr.1.2.87","volume":"1","author":"EA Belongia","year":"2003","unstructured":"Belongia, E. A. & Naleway, A. L. Smallpox vaccine: the good, the bad, and the ugly. Clin. Med. Res 1, 87\u201392 (2003).","journal-title":"Clin. Med. Res"},{"key":"591_CR58","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0264-410X(98)00248-5","volume":"17","author":"WT Jackman","year":"1999","unstructured":"Jackman, W. T., Mann, K. A., Hoffmann, H. J. & Spaete, R. R. Expression of Epstein\u2013Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine. Vaccine 17, 660\u2013668 (1999).","journal-title":"Vaccine"},{"key":"591_CR59","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1016\/j.vaccine.2007.04.008","volume":"25","author":"M Moutschen","year":"2007","unstructured":"Moutschen, M. et al. Phase I\/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein\u2013Barr virus vaccine in healthy adults. Vaccine 25, 4697\u20134705 (2007).","journal-title":"Vaccine"},{"key":"591_CR60","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/TP.0b013e3181b9d918","volume":"88","author":"L Rees","year":"2009","unstructured":"Rees, L. et al. A phase I trial of Epstein\u2013Barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation. Transplantation 88, 1025\u20131029 (2009).","journal-title":"Transplantation"},{"key":"591_CR61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.176.1.169","volume":"176","author":"R Khanna","year":"1992","unstructured":"Khanna, R. et al. Localization of Epstein\u2013Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J. Exp. Med. 176, 169\u2013176 (1992).","journal-title":"J. Exp. Med."},{"key":"591_CR62","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.171.1.345","volume":"171","author":"SR Burrows","year":"1990","unstructured":"Burrows, S. R., Sculley, T. B., Misko, I. S., Schmidt, C. & Moss, D. J. An Epstein\u2013Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). J. Exp. Med. 171, 345\u2013349 (1990).","journal-title":"J. Exp. Med."},{"key":"591_CR63","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","volume":"82","author":"SL Elliott","year":"2008","unstructured":"Elliott, S. L. et al. Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis. J. Virol. 82, 1448\u20131457 (2008).","journal-title":"J. Virol."},{"key":"591_CR64","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1016\/j.vaccine.2015.10.024","volume":"33","author":"E Servat","year":"2015","unstructured":"Servat, E. et al. Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo. Vaccine 33, 6771\u20136777 (2015).","journal-title":"Vaccine"},{"key":"591_CR65","doi-asserted-by":"crossref","first-page":"107fs107","DOI":"10.1126\/scitranslmed.3002878","volume":"3","author":"JI Cohen","year":"2011","unstructured":"Cohen, J. I., Fauci, A. S., Varmus, H. & Nabel, G. J. Epstein\u2013Barr virus: an important vaccine target for cancer prevention. Sci. Transl. Med. 3, 107fs107 (2011).","journal-title":"Sci. Transl. Med."},{"key":"591_CR66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/978-981-10-7230-7_22","volume":"1045","author":"JI Cohen","year":"2018","unstructured":"Cohen, J. I. Vaccine development for Epstein\u2013Barr virus. Adv. Exp. Med. Biol. 1045, 477\u2013493 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"591_CR67","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.vaccine.2013.04.071","volume":"31","author":"X Cui","year":"2013","unstructured":"Cui, X. et al. A novel tetrameric gp350 1\u2013470 as a potential Epstein\u2013Barr virus vaccine. Vaccine 31, 3039\u20133045 (2013).","journal-title":"Vaccine"},{"key":"591_CR68","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1016\/j.vaccine.2016.06.021","volume":"34","author":"X Cui","year":"2016","unstructured":"Cui, X. et al. Rabbits immunized with Epstein\u2013Barr virus gH\/gL or gB recombinant proteins elicit higher serum virus neutralizing activity than gp350. Vaccine 34, 4050\u20134055 (2016).","journal-title":"Vaccine"},{"key":"591_CR69","doi-asserted-by":"crossref","first-page":"7825","DOI":"10.1128\/JVI.00445-07","volume":"81","author":"LM Hutt-Fletcher","year":"2007","unstructured":"Hutt-Fletcher, L. M. Epstein\u2013Barr virus entry. J. Virol. 81, 7825\u20137832 (2007).","journal-title":"J. Virol."},{"key":"591_CR70","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-015-0415-2","volume":"13","author":"JG Ogembo","year":"2015","unstructured":"Ogembo, J. G. et al. A chimeric EBV gp350\/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice. J. Transl. Med. 13, 50 (2015).","journal-title":"J. Transl. Med."},{"key":"591_CR71","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","volume":"162","author":"M Kanekiyo","year":"2015","unstructured":"Kanekiyo, M. et al. Rational design of an Epstein\u2013Barr virus vaccine targeting the receptor-binding site. Cell 162, 1090\u20131100 (2015).","journal-title":"Cell"},{"key":"591_CR72","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.vaccine.2016.04.012","volume":"34","author":"DS Heeke","year":"2016","unstructured":"Heeke, D. S. et al. Identification of GLA\/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits. Vaccine 34, 2562\u20132569 (2016).","journal-title":"Vaccine"},{"key":"591_CR73","doi-asserted-by":"crossref","first-page":"e1005549","DOI":"10.1371\/journal.ppat.1005549","volume":"12","author":"JM Brooks","year":"2016","unstructured":"Brooks, J. M. et al. Early T cell recognition of B cells following Epstein\u2013Barr virus Infection: identifying potential targets for prophylactic vaccination. PLoS Pathog. 12, e1005549 (2016).","journal-title":"PLoS Pathog."},{"key":"591_CR74","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.immuni.2019.03.010","volume":"50","author":"W Bu","year":"2019","unstructured":"Bu, W. et al. Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein\u2013Barr virus in B cells and epithelial cells. Immunity 50, 1305\u20131316 e1306 (2019).","journal-title":"Immunity"},{"key":"591_CR75","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/infdis\/jit321","volume":"208","author":"HH Balfour Jr.","year":"2013","unstructured":"Balfour, H. H. Jr. et al. Age-specific prevalence of Epstein\u2013Barr virus infection among individuals aged 6\u201319 years in the United States and factors affecting its acquisition. J. Infect. Dis. 208, 1286\u20131293 (2013).","journal-title":"J. Infect. Dis."},{"key":"591_CR76","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/cid\/ciu342","volume":"59","author":"LM Condon","year":"2014","unstructured":"Condon, L. M. et al. Age-specific prevalence of Epstein\u2013Barr virus infection among Minnesota children: effects of race\/ethnicity and family environment. Clin. Infect. Dis. 59, 501\u2013508 (2014).","journal-title":"Clin. Infect. Dis."},{"key":"591_CR77","doi-asserted-by":"crossref","unstructured":"H\u00e4mmerl, L., Colombet, M., Rochford, R., Ogwang, M. & Parkin D. M. The burden of Burkitt lymphoma in Africa. Infect. Agent. Cancer 14, 17 (2019).","DOI":"10.1186\/s13027-019-0236-7"},{"key":"591_CR78","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMcp1001116","volume":"362","author":"K Luzuriaga","year":"2010","unstructured":"Luzuriaga, K. & Sullivan, J. L. Infectious mononucleosis. N. Engl. J. Med. 362, 1993\u20132000 (2010).","journal-title":"N. Engl. J. Med."},{"key":"591_CR79","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","volume":"4","author":"G Opelz","year":"2004","unstructured":"Opelz, G. & Dohler, B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am. J. Transplant. 4, 222\u2013230 (2004).","journal-title":"Am. J. Transplant."},{"key":"591_CR80","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/jnci\/92.18.1522","volume":"92","author":"H Hjalgrim","year":"2000","unstructured":"Hjalgrim, H. et al. Risk of Hodgkin\u2019s disease and other cancers after infectious mononucleosis. J. Natl. Cancer Inst. 92, 1522\u20131528 (2000).","journal-title":"J. Natl. Cancer Inst."},{"key":"591_CR81","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1044579X02000858","volume":"12","author":"MC Yu","year":"2002","unstructured":"Yu, M. C. & Yuan, J. M. Epidemiology of nasopharyngeal carcinoma. Semin. Cancer Biol. 12, 421\u2013429 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"591_CR82","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000316802.35974.34","volume":"71","author":"A Alonso","year":"2008","unstructured":"Alonso, A. & Hernan, M. A. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71, 129\u2013135 (2008).","journal-title":"Neurology"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0591-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0591-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T17:05:26Z","timestamp":1684861526000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0591-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,3]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0591-5","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,3]]},"assertion":[{"value":"1 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}